Lodewijk Mellema, Managing Director IMCD Benelux, comments: "With this acquisition IMCD expands its active pharmaceutical ingredients business primarily in Benelux and Vietnam and strengthens our company’s formulation and marketing synergies between active pharmaceutical ingredients and excipients in those regions”.
Erik van den Sigtenhorst, CEO Peak International, adds: “I am excited about the prospective of coupling Peak’s position in active pharmaceutical ingredients with IMCD’s geographic coverage, laboratory network and excellence in distribution of excipients. Our existing and future partners will be able to benefit from a significantly increased network within the pharmaceutical industry’’.
The acquired business will be integrated into IMCD Business Group Pharmaceuticals.
To read the full press release, please click on the link below:
This website uses cookies to improve your user experience
We use cookies for a variety of purposes, such as website functionality and helping target our marketing activities. Click "accept" to accept our cookies. You can change the cookie settings by clicking "change settings".